- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05298514
Data Sharing Project Part 2
Investigating Service User Opinions on Sharing Levels of Personal Information
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Stephanie Luff
- Phone Number: 80423
- Email: stephanie.luff@slam.nhs.uk
Study Contact Backup
- Name: Caroline da Cunha Lewin
- Phone Number: 80423
- Email: caroline.dacunhalewin@slam.nhs.uk
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Individuals who have experience of using mental health services or experienced mental health difficulties in the past.
- Aged 18 and above.
- Able to give informed consent.
- Ability to speak fluent English.
Exclusion Criteria:
- If identified through C4C, participants whose care team specify concerns regarding taking part in the study.
- People in whom significant concerns have been raised relating to risk, where risk refers to the extent to which an individual poses a threat to themselves (e.g. self-harm or suicidal intent).
- Inability to give informed consent, as judged by the clinician responsible for a service user's ongoing care, where applicable.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mental health service user opinions on clinical data sharing as explored through qualitative focus groups questions
Time Frame: Through study completion, an average of 1 year
|
To understand the requirements of service users, on issues such as privacy, usability, and acceptability of different tiers of data sharing. Furthermore, to investigate what service-users consider "identifiable" data, for example whether they consider identifiable data to be demographic information, location data (consisting of relative and absolute data) or purely their real name. This will be achieved by conducting a focus group in which the participants will be asked about hypothetical models of data sharing and their opinions on it. This will be guided by a topic guide asking the following questions:
|
Through study completion, an average of 1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Til Wykes, Clinical Doc, King's College London
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- LRS/DP-21/22-26411
- 310873 (Other Identifier: IRAS)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.